-The Times of India NEW DELHI: From July 1, you can walk up to a chemist and ask for a 'Jan Aushadhi' brand for your medicine, with the government set to launch its own brand to sell low cost generic medicines. The Centre will procure medicines in bulk from public as well as private drug manufacturing firms and rebrand them under 'Jan Aushadhi'. These will be sold in the retail market at...
More »SEARCH RESULT
Total Matching Records found : 943
More patent-opposition on Gilead’s hepatitis C drug, sofosbuvir -PT Jyothi Datta
-The Hindu Business Line Mumbai: A fresh bout of opposition has been filed against Gilead's patent application on hepatitis c drug sofosbuvir. This comes close on the heels of a spate of developments involving the drug, last month. Non-government organisation Sankalp Rehabilitation Trust, represented by the Lawyers Collective has filed a pre-grant opposition on the drug in the Delhi patent office. (A pre-grant opposition allows interested parties to oppose a patent application...
More »Hundreds of free drugs in states, only 50 in central scheme -Rema Nagarajan
-The Times of India The union health ministry's target of distributing 50 drugs free under the free essential drug scheme is so much lower than the hundreds of drugs being provided by states with a functioning free drugs scheme that it has left health officials in these states puzzled. After starting off by talking of distributing 348 drugs in the National List of Essential medicines (NLEM) during the tenure of Dr Harsh...
More »Has Modi succumbed US’ pressure on patents? -Kundan Pandey
-Down to Earth Prime minister's statement, agreeing to implement recommendations of India-US joint working group on intellectual property, would make medicines unaffordable for millions of needy, say health activists Prime Minister Narendra Modi's stand on Intellectual Property Rights (IPR) became clear when he assured Barack Obama that his government is ready to follow the recommendations of the US-India joint working group. Modi made this statement on Monday while addressing the CEO Forum...
More »Patented drug price
-PTI New Delhi: The drug price regulator has sought details of patented medicines as part of a drive to fix their rates. The National Pharmaceutical Pricing Authority (NPPA) is also fixing the price ceiling for 102 drugs on the National List of Essential medicines (NLEM) and has asked for financial data, like retail rates and the firms' turnover. On patented drugs imported or manufactured for sale in India, the NPPA has called for...
More »
